Use of the University of California Los Angeles Integrated Staging System (UISS) to predict survival in localized renal cell carcinoma in an Asian population

International Urology and Nephrology

Volumn 39, Issue 3, 2007, Pages 699-703

  Ng, Chi Fai ^a   Wan, Siu Ho ^a   Wong, Annie ^a   Lai, Fernand M M ^a   Hui, Pun ^a   Cheng, Chi Wai ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Algorithms; Carcinoma; Prognosis; Renal cell

Indexed keywords

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CANCER STAGING; CANCER SURVIVAL; CHINESE; CLINICAL ASSESSMENT TOOL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; PROGNOSIS; RATING SCALE; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; THORAX RADIOGRAPHY; UNIVERSITY OF CALIFORNIA LOS ANGELES INTEGRATED STAGING SYSTEM; VALIDATION STUDY;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; NEOPLASM STAGING; NEPHRECTOMY; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 34548442577     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-006-9134-1     Document Type: Article

References (23)

1. Chow WH, Devesa SS, Warren JL, et al (1999) Rising incidence of renal cell cancer in the United States. JAMA 281:1628-1631
2. Pantuck AJ, Zisman A, Belldegrun AS (2001) The Changing natural history of renal cell carcinoma. J Urol 166:1611-1623
3. Kontak JA, Campbell SC (2003) Prognostic factors in renal cell carcinoma. Urol Clin North Am 30:467-480
4. Zisman A, Pantuck AJ, Dorey F, et al (2001) Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19:1649-1657
5. Zisman A, Pantuck AJ, Wieder J, et al (2002) Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 20:4559-4566
6. Kattan MW, Reuter V, Motzer R, et al (2001) A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166:63-67
7. Frank I, Blute ML, Cheville JC, et al (2002) An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score. J Urol 168:2395-2400
8. Patard JJ, Kim HL, Lam JS, et al (2004) Use of the University of California Los Angeles Integrated Staging System to predict survival in renal cell carcinoma: An international multicenter study. J Clin Oncol 22:3316-3322
9. Sorbellini M, Kattan MW, Snyder ME, et al (2005) A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 173:48-51
10. Ficarra V, Martignoni G, Lohse C, et al (2006) External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol 175:1235-1239
11. Millward MJ, Boyer MJ, Lehnert M, et al (2003) Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients. Ann Oncol 14:449-454
12. Hashibe M, Gao T, Li G, et al (2003) Comparison of bladder cancer survival among Japanese, Chinese, Hawaiian and Caucasian populations in the United States. Asian Pac J Cancer Prev 4:267-273
13. Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment and survival by race and ethnicity. Arch Intern Med 163:49-56
14. Furhaman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655-663
15. Guinan P, Sobin LH, Alagaba F, et al (1997) TNM staging of renal cell carcinoma: Workgroup no 3 - Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:992-993
16. Oken MM, Creech RH, Tormey DC, et al. (1982) Toxicity and Response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655
17. Prehn AW, Topol B, Stewart S, et al (2002) Differences in treatment patterns for localized breast carcinoma among Asian/Pacific islander women. Cancer 95:2268-2275
18. Tseng JF, Kronowitz SJ, Sun CC et al: The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer, 2004; 101: 1514-1523. http://www.ncbi.nlm.nih.gov/entrez/utils/ lofref.fcgi?PrId=3058&uid=15378473&db=pubmed&url=http:// dx.doi.org/10.1002/cncr.20529
19. Wisnivesky JP, McGinn T, Henschke C, et al (2005) Ethnic disparities in the treatment of stage I non-small cell lung cancer. Am J Respir Crit Care Med 171:1158-63
20. Yang KS: Do traditional and modern values coexist in a modern Chinese society? In: Proceedings of the conference on Chinese perspectives on values. Taipei: Centre for sinological studies; 1992: 117-158
21. Ip M, Gilligan T, Koenig B, Raffin T (1998) Ethical decision-making in critical care in Hong Kong. Crit Care Med 26:447-451
22. Murphy AM, Gilbert SM, Katz AE, et al (2005) Re-evaluation of the Tumour-Node-Metastasis staging of locally advanced renal cortical tumours: Absolute size (T2) is more significant than renal capsular invasion (T3a). BJU int 95:27-30
23. Siemer S, Lehmann J, Loch A, et al (2005) Current TNM classification of renal cell carcinoma evaluated: Revising stage T3a. J Urol 173:33-37